This information is for research and educational purposes only. No medical recommendations. Products are not approved for human use. For health questions, consult a doctor.

Lexicon

Regeneration

Teriparatide

The active piece of parathyroid hormone (PTH 1-34), a clinically established agent that stimulates bone formation.

1 min read 1 sources Calculator Updated May 2026
Class
Parathyroid hormone fragment (PTH 1-34)
Use
Subcutaneous, daily (in mcg)
Half-life
short
Status
Clinically approved (osteoporosis)

Members only

Dosing recommendations are visible to logged-in members only. Logging in is free.

Log in / sign up

Equipment

Equipment you need

For reconstitution and injection you need a bit of basic gear. Here are solid, cheap options:

As an Amazon associate we earn from qualifying purchases. Links open Amazon - no extra cost for you.

What is Teriparatide?

Teriparatide is the active piece of the body's own parathyroid hormone (the first 34 amino acids, hence PTH 1-34). It is clinically approved for treating osteoporosis and one of the few agents that actively builds bone rather than just slowing breakdown.

How it works

The trick is in the timing: continuously elevated parathyroid hormone breaks down bone, while a once-daily short dose stimulates the bone-building cells (osteoblasts) more than the breaking-down ones. Net new bone forms, especially in the spine and hip.

What you need

  • The teriparatide vial (lyophilized powder).
  • Bacteriostatic water, U-100 insulin syringes, alcohol swabs.

Reconstitution

Use the calculator above. Teriparatide is dosed in mcg (in the calculator as a fraction of mg, 0.02mg is 20mcg). A 10mg vial with 2ml water gives 5mg per ml. Just add the water to the vial and let it dissolve.

Dosing

Members only

Dosing recommendations are visible to logged-in members only. Logging in is free.

Log in / sign up

Injection

Subcutaneous into the subcutaneous fat (abdomen or thigh). Disinfect the site, pinch a skin fold, rotate sites.

What the research shows

The approval study (Neer, NEJM 2001) showed a marked reduction of new vertebral fractures and an increase in bone density in postmenopausal women with osteoporosis. Teriparatide is thus a well-evidenced, clinically established agent with solid data.

Side effects

  • Dizziness, leg cramps, nausea, especially at the start.
  • Temporary rise in blood calcium.
  • Local reactions at the injection site.

Storage

Delicate: keep refrigerated throughout (2 to 8 degrees), do not freeze and protect from light.

Evidence

Sources

  1. 1 Parathyroid hormone (1-34) reduces fractures and increases bone density in osteoporosis (randomized). Neer et al., New England Journal of Medicine, 2001

Keep reading

More in the lexicon

In the shop

Teriparatide in the catalog

Sizes, prices and availability for research use. Straight from the lexicon to the product page.

View in shop